Keywords
erythrocytes
intensive care
mortality
prognosis
How to Cite
Abstract
OBJECTIVE: to assess whether the erythrocytes transfusion in the critically ill patient in our Intensive Care Unit (ICU) is associated with higher mortality.
DESIGN: A retrospective observational study was made since January 2009 to December 2018.
SETTING: An ICU in a tertiary hospital.
PATIENTS: Patients of 18 years old or older, from both sexes, hospitalized for at least 24 hours.
INTERVENTIONS: None.
VARIABLES OF INTEREST: Number of erythrocytes transfusions and ICU mortality.
RESULTS: Data of 4244 patients, who gathered the required information, were analyzed. The average age was50,35 (±17,14) years, 64,6% were male, the average days of hospitalization in ICU were6,61 (±8,94) days, APACHE II 14,74 (±8,67), SAPS II 36,87 (±19,40), SOFA 4,96 (±3,72), 46,9% required mechanical ventilation and mortality was 24,6%. 735 patients required erythrocytes transfusions (17.3%). When these were compared with those not transfused, it was observed that the former presented younger age (51 vs. 53 years, p <0.001), higher severity scores (APACHE II 17 vs. 13 p <0.001; SAPS II 40 vs. 32 p <0.001; SOFA 6 vs. 4 p <0.001), longer ICU stay (6 vs. 3 days, p <0.001), need of mechanical ventilation (65.7 vs. 42.9%, p <0.001) and mortality (34 vs. 22.6%, <0.001). The multivariate logistic regression analysis showed that the patients with the highest number of erythrocytes transfusion presented higher mortality in the ICU [odds ratio of 1.066 (95% CI: 1.015-1.119; p 0.01)], adjusting for age, days of hospitalization, severity scales and need for VM.
CONCLUSION: From these results we can conclude that erythrocytes transfusion in critically ill patients was associated with higher mortality in our ICU.
The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.